Edvardas Golovinas's research while affiliated with Vilnius University and other places

What is this page?


This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.

It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.

If you're a ResearchGate member, you can follow this page to keep up with this author's work.

If you are this author, and you don't want us to display this page anymore, please let us know.

Publications (9)


The missing part: the Archaeoglobus fulgidus Argonaute forms a functional heterodimer with an N-L1-L2 domain protein
  • Article
  • Full-text available

January 2024

·

40 Reads

·

1 Citation

Nucleic Acids Research

·

Edvardas Golovinas

·

Reda Pocevičiūtė

·

[...]

·

Argonaute (Ago) proteins are present in all three domains of life (bacteria, archaea and eukaryotes). They use small (15–30 nucleotides) oligonucleotide guides to bind complementary nucleic acid targets and are responsible for gene expression regulation, mobile genome element silencing, and defence against viruses or plasmids. According to their domain organization, Agos are divided into long and short Agos. Long Agos found in prokaryotes (long-A and long-B pAgos) and eukaryotes (eAgos) comprise four major functional domains (N, PAZ, MID and PIWI) and two structural linker domains L1 and L2. The majority (∼60%) of pAgos are short pAgos, containing only the MID and inactive PIWI domains. Here we focus on the prokaryotic Argonaute AfAgo from Archaeoglobus fulgidus DSM4304. Although phylogenetically classified as a long-B pAgo, AfAgo contains only MID and catalytically inactive PIWI domains, akin to short pAgos. We show that AfAgo forms a heterodimeric complex with a protein encoded upstream in the same operon, which is a structural equivalent of the N-L1-L2 domains of long pAgos. This complex, structurally equivalent to a long PAZ-less pAgo, outperforms standalone AfAgo in guide RNA-mediated target DNA binding. Our findings provide a missing piece to one of the first and the most studied pAgos.

Download
Share

Analysis of in vivo (E. coli) AfAgo-bound nucleic acids. (a) Top-Digestion of AfAgo nucleic acids with DNAse I and RNase A. Bottom-Size analysis of AfAgo-bound RNA. (b) Read length distribution of sequenced AfAgo-bound nucleic acids. (c) Sequencing read alignments to the AfAgo expression vector. 73% of all reads map to the expression vector, compared to 27% to E. coli genome (Supplementary file 1). (d) Small RNAs copurified with AfAgo show 5′-AUU bias.
AfAgo interactions with nucleic acids in vitro. EMSA experiments were performed with 5 nM total 5′P-ssRNA (a) and ssDNA (b), and varying concentrations of AfAgo, indicated above each lane. Calculated Kd values are provided in Table 1.
AfAgo RNA-guided NA targeting mechanism and double-stranded nucleic acid binding probed using EMSA. (a) Titration of labelled target ssDNA (top) and ssRNA (bottom) with a pre-formed AfAgo-guide RNA complex (1:2 ratio, AfAgo concentrations indicated above each lane) for either 8 nt complementary (left) or 4 nt complementary (lc-“low complementarity”, right) targets. A schematic of guide-target complementarity is shown adjacent to each respective gel, with 5′-terminal bases of the guide and 3′-terminal bases relevant to AfAgo base recognition highlighted in black, remaining strands in grey. 5′³²P-labelled target strands are denoted with an asterisk. Cd-duplex control, where guide and target were mixed in the absence of AfAgo at a ratio equivalent to lane “200”. Ct-target control, where RNA-free AfAgo was mixed with the target at a ratio equivalent to lane “200”. (b) Experiment equivalent to (a), left, conducted in the presence of 100 ng/µl heparin.
Structure of the AfAgo-DNA complex. (a) The 5′-ATT DNA oligoduplex used for crystallization. (b) The overall structure of the AfAgo-DNA complex. The backbone of DNA strands is coloured as in A. DNA bases are transparent. The Mg²⁺ ion involved in coordination of the 5′-phosphate of the guide strand is shown as a magenta sphere. (c) Schematic representation of AfAgo contacts with the DNA.
AfAgo interaction with the first three base pairs of the 5′-ATT DNA duplex. gA1 (a) and tT1‘ (b) in their respective pockets. (c, d) Recognition of gT2 and tA2’ of the second base pair. (e, f) Interactions with gT3 and tA3’ of the third base pair.
Structural basis for sequence-specific recognition of guide and target strands by the Archaeoglobus fulgidus Argonaute protein

April 2023

·

67 Reads

·

2 Citations

Scientific Reports

Argonaute (Ago) proteins are found in all three domains of life. The best-characterized group is eukaryotic Argonautes (eAgos). Being the structural core of RNA interference machinery, they use guide RNA molecules for RNA targeting. Prokaryotic Argonautes (pAgos) are more diverse, both in terms of structure (there are eAgo-like ‘long’ and truncated ‘short’ pAgos) and mechanism, as many pAgos are specific for DNA, not RNA guide and/or target strands. Some long pAgos act as antiviral defence systems. Their defensive role was recently demonstrated for short pAgo-encoding systems SPARTA and GsSir2/Ago, but the function and action mechanisms of all other short pAgos remain unknown. In this work, we focus on the guide and target strand preferences of AfAgo, a truncated long-B Argonaute protein encoded by an archaeon Archaeoglobus fulgidus. We demonstrate that AfAgo associates with small RNA molecules carrying 5′-terminal AUU nucleotides in vivo, and characterize its affinity to various RNA and DNA guide/target strands in vitro. We also present X-ray structures of AfAgo bound to oligoduplex DNAs that provide atomic details for base-specific AfAgo interactions with both guide and target strands. Our findings broaden the range of currently known Argonaute-nucleic acid recognition mechanisms.


Structural basis for sequence-specific recognition of guide and target strands by the Archaeoglobus fulgidus Argonaute protein

November 2022

·

77 Reads

Argonaute (Ago) proteins are found in all three domains of life. The best-characterized group is eukaryotic Argonautes (eAgos). Being the structural core of RNA interference machinery, they use guide RNA molecules for RNA targeting. Prokaryotic Argonautes (pAgos) are more diverse, both in terms of structure (there are eAgo-like ‘long’ and truncated ‘short’ pAgos) and mechanism, as many pAgos are specific for DNA, not RNA guide and/or target strands. Some long pAgos act as antiviral defence systems. Their defensive role was recently demonstrated for short pAgo-encoding systems SPARTA and GsSir2/Ago, but the function and action mechanisms of all other short pAgos remain unknown. In this work, we focus on the guide and target strand preferences of AfAgo, a short Argonaute protein encoded by an archaeon Archaeoglobus fulgidus . We demonstrate that AfAgo associates with small RNA molecules carrying 5′-terminal AUU nucleotides in vivo , and characterize its affinity to various RNA and DNA guide/target strands in vitro . We also present X-ray structures of AfAgo bound to oligoduplex DNAs that provide atomic details for base-specific AfAgo interactions with both guide and target strands. Our findings broaden the range of currently known Argonaute-nucleic acid recognition mechanisms.


Sir2/Ago provides defence against phages
a, Schematic representation of the subunit/domain composition of different pAgo variants. Catalytically active pAgos contain a conserved catalytic DEDX tetrad that is mutated in inactive pAgos. Catalytically inactive short pAgos lack the canonical PAZ domain; however, an accessory APAZ domain is present in putative Sir2, TIR or Mrr proteins associated with short pAgos. MID, middle; L, linker domain; N,N-terminal domain. Short pAgos from G. sulfurreducens, C. cordobensis and P. graminis associated with Sir2 protein were studied in this work. b, Schematic diagram of phage restriction assays. c, Bottom: EOP of lambda-vir and SECphi27 phages infecting E. coli cells with and without the GsSir2/Ago system. The bar graphs show the number of plaque-forming units (p.f.u.) as arithmetic means of two replicates in the absence and the presence of the inducer l-arabinose (l-Ara), with individual data points superimposed. Grey and black bars respectively represent EOP on pAgo-lacking and pAgo-containing cells. Top: representative images of plaque assays. d, EOP of lambda-vir and SECphi27 phages infecting the wt and mutant GsSir2/Ago systems in the presence of l-Ara. GsSir2(D230A)/Ago and GsSir2/Ago-HSH are variants that contain a D230A mutation in the Sir2 domain or an HSH-tag on the C terminus of pAgo, respectively. The bar graphs show the number of p.f.u. as arithmetic means of three replicates, with individual data points superimposed. Grey and black bars respectively represent EOP on pAgo-lacking and pAgo-containing cells. e, EOP of lambda-vir and SECphi27 phages infecting pAgo-lacking cells and cells containing GsSir2/Ago, CcSir2/Ago and PgSir2-Ago in the presence of l-Ara. The bar graphs show the number of p.f.u. as arithmetic means of three replicates, with individual data points superimposed. Grey and black bars respectively represent EOP on pAgo-lacking and pAgo-containing cells. f, Lambda phage infection in liquid cultures of E. coli cells containing the GsSir2/Ago system. GsSir2/Ago-lacking (shown in grey) or GsSir2/Ago-containing (shown in orange) E. coli were infected at t = 0 at MOI of 0.05, 0.5 and 5. Each curve represents one individual replicate; two replicates for each MOI are shown.
Source data
The GsSir2/Ago system interferes with plasmid transformation
a, Schematic representation of the experiment. TE, transformation evaluation. b, Qualitative evaluation of plasmid transformation efficiency in E. coli cells carrying the GsSir2/Ago system. Top: comparison of cell viability in the presence or absence of plasmid-borne GsSir2/Ago expression. Bottom: comparison of plasmid transformation efficiencies in the presence or absence of plasmid-borne GsSir2/Ago expression. c, Left: comparison of pCDF transformation efficiency between cells expressing wt and mutant GsSir2/Ago complexes. Right: quantification of transformation efficiencies (three independent replicates, the red line represents average transformation efficiency). d, Top: schematic representation of ori exchange between pCDF and pCOLA plasmids. Bottom: comparison of plasmid transformation efficiencies. pCDF, pCDF with CloDF13 ori exchanged with ColA ori (pCDF_ColA), pCOLA and pCOLA with ColA ori exchanged with CloDF13 ori (pCOLA_CloDF13) plasmids were used for transformation of E. coli cells carrying the GsSir2/Ago system. e, Cell viability in the absence of antibiotic selection. In the case of the wt GsSir2/Ago system, cell viability decreased on the plates even in the absence of Cb and Str antibiotics, suggesting that GsSir2/Ago in the presence of the pCDF plasmid triggers cell death.
Source data
The GsSir2 and GsAgo proteins form a heterodimeric complex
a, Top: Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) of purified wt GsSir2/Ago, a D230A mutant, and C-terminal HSH-tag-bearing GsSir2/Ago. The red star in the HSH-tagged sample lane marks an overlap of bands in the gel due to similar mass. Bottom: anti-His-tag western blot of same samples. The red star shows the lane where the His-tag is on the C terminus of Ago, rather than the N terminus of Sir2. Two replicates. b, Mass photometry data of the GsSir2/Ago complex, with masses and respective particle population counts indicated. According to mass spectrometry of the purified GsSir2/Ago complex (Extended Data Fig. 3f), the molar mass of the GsSir2/Ago heterodimer is 121 kDa. c, SEC-MALS data of GsSir2/Ago showing the chromatography peak and molar weight of the Sir2/Ago heterodimer. d, Semitransparent space-filling ab initio model of GsSir2/Ago calculated from SAXS data with a fitted-in AlphaFold GsSir2/Ago model in cartoon representation. Colour coding: cyan, Sir2 domain; brown, APAZ; yellow, MID; green, PIWI.
Source data
Nucleic acid binding by GsSir2/Ago in vitro and in vivo
a, Binding of RNA or DNA targets by GsSir2/Ago binary complexes pre-loaded with 5’P-RNA or 5’P-DNA guides. In EMSA experiments, the pre-formed GsSir2/Ago-gNA binary complex was mixed with a radiolabelled target strand indicated by the asterisk (see Materials and Methods for details). To show that no displacement of the guide by the target strand occurs under these experimental conditions, a control (Cg*) experiment was performed where the guide, rather than the target, was radioactively labelled. Only the pre-annealed RNA/DNA heteroduplex was loaded in the control lane ‘d’. Three independent replicates were performed. b, GsSir2/Ago co-purifies with small RNAs. Nucleic acids that co-purified with GsSir2/Ago were first dephosphorylated, then [γ-³²P]-ATP radiolabelled and treated with DNase I or RNase A/T1, or both, and resolved on a denaturing polyacrylamide gel. R, control 22 nt RNA oligonucleotide; M, RNA ladder Decade Marker System (Ambion). Three independent replicates were performed. c, Length distribution of small RNA co-purified with GsSir2/Ago as determined by sequencing. In the ‘5’P-RNA’ sample, only small RNAs containing 5’-phosphate were sequenced, while in the ‘5’P+5’OH-RNA’ sample, both 5’-phosphate or 5’-OH-bearing small RNAs were sequenced. d, Small RNAs associated with GsSir2/Ago show 5’-AU preference. e, Top: distribution of small RNAs co-purified with GsSir2/Ago from the E. coli host carrying the pCDF_Kn target (left) and pBAD_GsSir2/Ago expression plasmids (right). Bottom: corresponding IGV viewer representations of total RNA extracted from E. coli. Cartoons indicate promoters (PBAD), protein-coding genes (KanR, LacI, GsSir2, GsAgo, AmpR, AraC), plasmid ori (CloDF13, ColE1) and their RNAI and RNAII transcripts. Red arrow shows RNase H cleavage site in RNAII required for initiation of DNA strand synthesis during plasmid replication.
Source data
GsSir2/Ago binds and hydrolyses NAD⁺
a, The D230A mutation within the Sir2 protein abolished NAD⁺ binding. b, NAD⁺ amounts in E. coli cells in the presence of the non-induced wt and mutant GsSir2/Ago systems, and in the presence and absence of the pCDF plasmids. NAD⁺ amounts were estimated according to the extracted ion current (EIC) areas of NAD⁺ (m/z 662.1018). pBAD, empty vector; wt, GsSir2/Ago; D230A, GsSir2(D230A)/Ago; HSH, GsSir2/Ago-HSH. c, NAD⁺ depletion by GsSir2/Ago in vitro. The wt GsSir2/Ago or mutant complex (0.5 μM) was incubated with NAD⁺ (50 μM) for 1 h at 37 °C (see experimental details in Materials and Methods). gRNA, 5’P-RNA guide; tDNA, target DNA complementary to the RNA guide; nsp-tDNA, ssDNA non-complementary to the RNA guide. d, NAD⁺ hydrolysis by wt GsSir2/Ago in vitro. The binary GsSir2/Ago-gRNA complex (0.5 μM) was incubated with NAD⁺ (50 μM) for 1 h at 37 °C in the presence of the complementary DNA target (0.5 μM). NAD⁺ depletion and ADPR accumulation were analysed by MS according to the EIC of NAD⁺ (m/z 662.1018) and ADPR (m/z 558.0644), respectively. AC, the activated wt GsSir2/Ago-gRNA/tDNA complex. e, Representative mass chromatograms of NAD⁺ hydrolysis by wt GsSir2/Ago in vitro (as in d). C, a control sample without GsSir2/Ago. f, Putative model of GsSir2/Ago defence against mobile genetic elements. After lambda phage infection or pCDF plasmid transformation, GsSir2/Ago acquires small 5’-AU-RNAs originating from the invader transcripts (for example, from the pCDF ori region). The GsSir2/Ago binary complex, guided by small RNA, targets the invaders’ complementary DNA, becomes activated and hydrolyses NAD⁺ resulting in cell death.
Source data
Short prokaryotic Argonautes provide defence against incoming mobile genetic elements through NAD depletion

October 2022

·

190 Reads

·

57 Citations

Nature Microbiology

Argonaute (Ago) proteins are found in all three domains of life. The so-called long Agos are composed of four major domains (N, PAZ, MID and PIWI) and contribute to RNA silencing in eukaryotes (eAgos) or defence against invading mobile genetic elements in prokaryotes (pAgos). The majority (~60%) of pAgos identified bioinformatically are shorter (comprising only MID and PIWI domains) and are typically associated with Sir2, Mrr or TIR domain-containing proteins. The cellular function and mechanism of short pAgos remain enigmatic. Here we show that Geobacter sulfurreducens short pAgo and the NAD⁺-bound Sir2 protein form a stable heterodimeric complex. The GsSir2/Ago complex presumably recognizes invading plasmid or phage DNA and activates the Sir2 subunit, which triggers endogenous NAD⁺ depletion and cell death, and prevents the propagation of invading DNA. We reconstituted NAD⁺ depletion activity in vitro and showed that activated GsSir2/Ago complex functions as a NADase that hydrolyses NAD⁺ to ADPR. Thus, short Sir2-associated pAgos provide defence against phages and plasmids, underscoring the diversity of mechanisms of prokaryotic Agos.


Fig. 1. Sir2/Ago provide defence against phages. A, Schematic representation of different pAgo systems. Individual domains are colour-coded. Catalytically active pAgos contain a conserved catalytic DEDX tetrad that is mutated in the
Fig. 4. Nucleic acid binding by GsSir2/Ago in vitro. A, EMSA of GsSir2/Ago binding to various DNA and RNA oligonucleotides. The asterisk denotes the radiolabelled strand. B, Binding of different targets by binary complexes preloaded with RNA or DNA guides. The pre-formed GsSir2/Ago complex with the guide strand (binary complex) was mixed with a radiolabelled target strand (see experimental details in "Materials and Methods"). Cg* denotes a control lane, equivalent to experimental lane marked by a black triangle, but with the guide, rather than the target, bearing the radioactive label. No displacement of the radiolabelled guide by the target strand is observed.
Fig. 5. The GsSir2/Ago complex binds NAD + in vitro and causes NAD + depletion in E. coli cells. A, MS/MS calibration curve of NAD + standard (marked in black) and the observed amount of NAD + in three samples: 93.7 pmol in the wt GsSir2/Ago sample (marked in green), 0.7 pmol in the sample D230A (marked in red). B, the D230A mutation within the Sir2 protein abolished NAD + binding. C, NAD + amount in E. coli cells in the presence of the (non)induced wt and mutant GsSir2/Ago systems and in the presence and absence of the pCDF plasmids. NAD + amounts were estimated according to the EIC areas of NAD + (m/z 662.1018). pBAD -empty vector; wt -GsSir2/Ago; D230A -GsSir2(D230A)/Ago; HSH -GsSir2/Ago-HSH. D, Putative model of GsSir2/Ago defence against mobile genetic elements. After lambda phage infection or pCDF plasmid transformation, the GsSir2/Ago system becomes activated and triggers NAD + depletion and cell death. Recognition of the CloDF13 replication origin of pCDF plasmid seems to be a major factor that triggers NAD + depletion by the Sir2 domain.
Sir2-domain associated short prokaryotic Argonautes provide defence against invading mobile genetic elements through NAD+ depletion

December 2021

·

156 Reads

Argonaute (Ago) proteins are found in all three domains of life. The so-called long Agos are composed of four major domains (N, PAZ, MID, and PIWI) and contribute to RNA silencing in eukaryotes (eAgos) or defence against invading mobile genetic elements in prokaryotes (pAgos). Intriguingly, the majority (~60%) of prokaryotic Agos (pAgos) identified bioinformatically are shorter (comprised of only MID and PIWI domains) and are typically associated with Sir2, Mrr or TIR domain-containing proteins. The cellular function and mechanism of short pAgos remain enigmatic. Here, we show that short pAgos from Geobacter sulfurreducens , Caballeronia cordobensis and Paraburkholderia graminis , together with the NAD ⁺ -bound Sir2-proteins form a stable heterodimeric Sir2/Ago complex that recognizes invading plasmid or phage DNA through the pAgos subunit and activates Sir2 subunit triggering the endogenous NAD ⁺ depletion and cell death thus preventing the propagation of invading DNA. This is the first demonstration that short Sir2-associated pAgos provide defence against phages and plasmids and underscores the diversity of mechanisms of prokaryotic Agos.


Fig. 1 Sir2/Ago provide defence against phages. A, Schematic representation of different pAgo systems. Individual domains are colour-coded. Catalytically active pAgos contain a conserved catalytic DEDX tetrad that is mutated in the inactive pAgos. Catalytically inactive short pAgos lack the canonical PAZ (PIWI-Argonaute-Zwille) domain, however,
Fig. 4. Nucleic acid binding by GsSir2/Ago in vitro. A, EMSA of GsSir2/Ago binding to various DNA and RNA oligonucleotides. The asterisk denotes the radiolabelled strand. B, Binding of different targets by binary complexes preloaded with RNA or DNA guides. The pre-formed GsSir2/Ago complex with the guide strand (binary complex) was mixed with a radiolabelled target strand (see experimental details in "Materials and Methods"). Cg* denotes a control lane, equivalent to experimental lane marked by a black triangle, but with the guide, rather than the target, bearing the radioactive label. No displacement of the radiolabelled guide by the target strand is observed.
Fig. 6 Putative model of GsSir2/Ago defence against mobile genetic elements. After lambda phage infection or pCDF plasmid transformation, the GsSir2/Ago system becomes activated and triggers NAD + depletion and cell death. Recognition of the CloDF13 replication origin of pCDF plasmid seems to be a major factor that triggers NAD + depletion by the Sir2 domain.
Sir2-domain associated short prokaryotic Argonautes provide defence against invading mobile genetic elements through NAD+ depletion

December 2021

·

195 Reads

·

5 Citations

Argonaute (Ago) proteins are found in all three domains of life. The so-called long Agos are composed of four major domains (N, PAZ, MID, and PIWI) and contribute to RNA silencing in eukaryotes (eAgos) or defence against invading mobile genetic elements in prokaryotes (pAgos). Intriguingly, the majority (~60%) of prokaryotic Agos (pAgos) identified bioinformatically are shorter (comprised of only MID and PIWI domains) and are typically associated with Sir2, Mrr or TIR domain-containing proteins. The cellular function and mechanism of short pAgos remain enigmatic. Here, we show that short pAgos from Geobacter sulfurreducens, Caballeronia cordobensis and Paraburkholderia graminis, together with the NAD+-bound Sir2-proteins form a stable heterodimeric Sir2/Ago complex that recognizes invading plasmid or phage DNA through the pAgos subunit and activates Sir2 subunit triggering the endogenous NAD+ depletion and cell death thus preventing the propagation of invading DNA. This is the first demonstration that short Sir2-associated pAgos provide defence against phages and plasmids and underscores the diversity of mechanisms of prokaryotic Agos.


Prokaryotic Argonaute from Archaeoglobus fulgidus interacts with DNA as a homodimer

February 2021

·

182 Reads

·

9 Citations

Scientific Reports

Argonaute (Ago) proteins are found in all three domains of life. The best-characterized group is eukaryotic Argonautes (eAgos), which are the core of RNA interference. The best understood prokaryotic Ago (pAgo) proteins are full-length pAgos. They are composed of four major structural/functional domains (N, PAZ, MID, and PIWI) and thereby closely resemble eAgos. It was demonstrated that full-length pAgos function as prokaryotic antiviral systems, with the PIWI domain performing cleavage of invading nucleic acids. However, the majority of identified pAgos are shorter and catalytically inactive (encode just MID and inactive PIWI domains), thus their action mechanism and function remain unknown. In this work we focus on AfAgo, a short pAgo protein encoded by an archaeon Archaeoglobus fulgidus . We find that in all previously solved AfAgo structures, its two monomers form substantial dimerization interfaces involving the C-terminal β-sheets. Led by this finding, we have employed various biochemical and biophysical assays, including SEC-MALS, SAXS, single-molecule FRET, and AFM, to show that AfAgo is indeed a homodimer in solution, which is capable of simultaneous interaction with two DNA molecules. This finding underscores the diversity of prokaryotic Agos and broadens the range of currently known Argonaute-nucleic acid interaction mechanisms.


Prokaryotic Argonaute From Archaeoglobus Fulgidus Interacts With DNA as a Homodimer

December 2020

·

74 Reads

Argonaute (Ago) proteins are found in all three domains of life. The best characterized group is eukaryotic Argonautes (eAgos), which are the core of RNA interference. The best understood prokaryotic Ago (pAgo) proteins are full-length pAgos. They are composed of four major structural/functional domains (N, PAZ, MID and PIWI) and thereby closely resemble eAgos. It was demonstrated that full-length pAgos function as prokaryotic antiviral systems, with the PIWI domain performing cleavage of invading nucleic acids. However, the majority of identified pAgos are shorter and catalytically inactive (encode just MID and inactive PIWI domains), thus their action mechanism and function remain unknown. In this work we focus on AfAgo, a short pAgo protein encoded by an archaeon Archaeoglobus fulgidus . We find that in all previously solved AfAgo structures, its two monomers form substantial dimerization interfaces involving the C-terminal β-sheets. Led by this finding, we have employed various biochemical and biophysical assays, including SEC-MALS, SAXS, single-molecule FRET and AFM, to show that AfAgo is indeed a homodimer in solution, which is capable of simultaneous interaction with two DNA molecules. This finding underscores the diversity of prokaryotic Agos and broadens the range of currently known Argonaute-nucleic acid interaction mechanisms.


Figure 5. Kinetic schemes depicting possible reaction pathways between two-target site DNA fragment and AfAgo. Black bars represent DNA, rectangular boxes -AfAgo-binding targets, circlesAfAgo monomers. Pathway of states 0 through 3 represents the case of stable AfAgo dimer and is the dominant pathway. Pathway 0-4-5-2 describes the reactions in the case where AfAgo is a monomer assembling into a dimer once two monomers bind to different sites on the DNA fragment and is a minor pathway. Dashed box represents states limited to AfAgoΔ.
Prokaryotic Argonaute from Archaeoglobus fulgidus interacts with DNA as a homodimer

May 2020

·

82 Reads

Background Argonaute (Ago) proteins are found in all three domains of life. The best characterized group is eukaryotic Argonautes (eAgos), which are the core of RNA interference. The best understood prokaryotic Ago (pAgo) proteins are full-length pAgos. They are monomeric proteins, all composed of four major structural/functional domains (N, PAZ, MID and PIWI) and thereby closely resemble eAgos. It is believed that full-length pAgos function as prokaryotic antiviral systems, with the PIWI domain performing cleavage of invading nucleic acids. However, the majority of identified pAgos are shorter and catalytically inactive (encode just MID and inactive PIWI domains), thus their action mechanism and function remain unknown. Results In this work we focus on AfAgo, a short pAgo protein encoded by an archaeon Archaeoglobus fulgidus . We find that in all previously solved AfAgo structures, its two monomers form substantial dimerization interfaces involving the C-terminal β-sheets. Led by this finding, we have employed various biochemical and biophysical assays, including single-molecule FRET, SAXS and AFM, to test the possible dimerization of AfAgo. SAXS results confirm that WT AfAgo, but not the dimerization surface mutant AfAgoΔ, forms a homodimer both in the apo-form and when bound to a nucleic acid. Single molecule FRET and AFM studies demonstrate that the dimeric WT AfAgo binds two ends of a linear DNA fragment, forming a relatively stable DNA loop. Conclusion Our results show that contrary to other characterized Ago proteins, AfAgo is a stable homodimer in solution, which is capable of simultaneous interaction with two DNA molecules. This finding broadens the range of currently known Argonaute-nucleic acid interaction mechanisms.

Citations (5)


... Recently, nucleases co-encoded with inactive long pAgos were shown to participate in anti-phage defence through nonspecific DNA degradation, although their activity was not strictly inhibited in the absence of target DNA 43 . Other types of effectors associated with inactive long and split ('pseudo-short') pAgos also probably play defensive functions [43][44][45] . ...

Reference:

DNA-targeting short Argonautes complex with effector proteins for collateral nuclease activity and bacterial population immunity
The missing part: the Archaeoglobus fulgidus Argonaute forms a functional heterodimer with an N-L1-L2 domain protein

Nucleic Acids Research

... However, the biological role of AfAgo remains elusive. The recently demonstrated AfAgo ability to form homodimeric assemblies that can bring together two copies of the guidetarget duplex ( 20 ) , and its intrinsic specificity to 3 nucleotides of both RNA guide and DNA target strands ( 21 ) distinguish it from previously characterized monomeric Argonaute proteins, that limit specific recognition of terminal nucleotides either to the guide strand ( e.g. RsAgo, PDB ID: 6d8p ( 22 ) ) , or to the target strand ( 23 ) , raising further questions regarding AfAgo functions in vivo . ...

Structural basis for sequence-specific recognition of guide and target strands by the Archaeoglobus fulgidus Argonaute protein

Scientific Reports

... Argonaute proteins are ubiquitous across all three domains of life. Initially discovered in eukaryotes (eAgos) as components of interference for gene expression regulation, shorter pAgos contribute to defense against phages by collaborating with various known antiphage effectors [68][69][70]. pAgos can be classified into long pAgos and short pAgos. Long pAgos, whether they possess nucleic acid cleavage capabilities (long-A pAgos) or not (long-B pAgos), are involved in the nucleic acid degradation strategy. ...

Short prokaryotic Argonautes provide defence against incoming mobile genetic elements through NAD depletion

Nature Microbiology

... Short pAgos are inactive as a result of the mutation of the catalytic tetrad, and their functions have been a mystery for a long time until most recently. It was reported that short pAgos and a (preduso)short pAgo from Sulfolobus islandicus (Si) constitute defense systems together with their associated proteins [20][21][22][23][24] . These short pAgos systems confer immunity against viruses and plasmids via an abortive infection (Abi) response 25 , a defense strategy kills the infected cells or induces cell dormancy to suppress the spreading of the invaders 26 . ...

Sir2-domain associated short prokaryotic Argonautes provide defence against invading mobile genetic elements through NAD+ depletion

... However, the biological role of AfAgo remains elusive. The recently demonstrated AfAgo ability to form homodimeric assemblies that can bring together two copies of the guidetarget duplex ( 20 ) , and its intrinsic specificity to 3 nucleotides of both RNA guide and DNA target strands ( 21 ) distinguish it from previously characterized monomeric Argonaute proteins, that limit specific recognition of terminal nucleotides either to the guide strand ( e.g. RsAgo, PDB ID: 6d8p ( 22 ) ) , or to the target strand ( 23 ) , raising further questions regarding AfAgo functions in vivo . ...

Prokaryotic Argonaute from Archaeoglobus fulgidus interacts with DNA as a homodimer

Scientific Reports